Repair what is lost: Neuroprotection through neural stem cells in progressive MS

Genchi et al.(1) report the first phase 1 trial of neural stem cell transplantation in multiple sclerosis showing a reduction in gray matter atrophy. Results give hope for a new era of induced neuroprotection, especially in progressive multiple sclerosis.

Detalles Bibliográficos
Autores principales: Schoonheim, Menno M., Strijbis, Eva M.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Spotlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040451/
https://www.ncbi.nlm.nih.gov/pubmed/36948155
http://dx.doi.org/10.1016/j.xcrm.2023.100985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040451/
https://www.ncbi.nlm.nih.gov/pubmed/36948155
http://dx.doi.org/10.1016/j.xcrm.2023.100985

Ejemplares similares